Go
All Publishers
24-7 Press Release Newswire
3BL Media
AccessWire
Brandpoint
Chainwire
Evertise Digital
EZ Newswire
GlobeNewswire
Get Featured
Investor Brand Network
iCrowdNewswire
KeyCrew
Prodigy Press Wire
KoreWire
Law Firm Newswire
Media OutReach
MoneyShow Newswire
NewsDirect
NewsUSA
Newsworthy.ai
Pinion Newswire
Press Advantage
PR.com
PR Newswire
PRUnderground
FirstPublisher
RestaurantNews.com
Send2Press
Syndication Cloud
Press Services
Shan News Network
StatePoint Media
WebWire
Monday, June 8, 2026
PR Newswire
Today at 9:00pm UTC
Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type...
GlobeNewswire
Today at 9:00pm UTC
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
PR Newswire
Today at 8:45pm UTC
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
PR Newswire
Today at 8:45pm UTC
GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders
GlobeNewswire
Today at 7:40pm UTC
Photo Scanning Services 2026 - iMemories Launched Photo Scanning Services for Families Across the USA
GlobeNewswire
Today at 7:30pm UTC
Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than...
PR Newswire
Today at 6:30pm UTC
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss...
GlobeNewswire
Today at 6:30pm UTC
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
PR Newswire
Today at 6:30pm UTC
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and...
GlobeNewswire
Today at 6:30pm UTC
Butler County Jury Returns $12.5 Million Verdict Against Chesterwood Village, Including Punitive Damages, in Wrongful Death of 83-Year-Old...
PR Newswire
Today at 5:40pm UTC
Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a...
GlobeNewswire
Today at 5:30pm UTC
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action ...
GlobeNewswire
Today at 4:46pm UTC
Landless Theatre Company Presents EVIL LIBRARIAN: A New Musical in Washington, DC
PR Newswire
Today at 4:17pm UTC
Bronstein, Gewirtz & Grossman LLC Urges CommVault Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
PR Newswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Calix, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
PR Newswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
<
1
2
3
4
5
6
...
19
20
>
Home
E-Edition
News
Obituaries
Sports
Opinion
Records
Contests
Services
Classifieds
Public Notices
Calendar
Subscribe
Home
News
Features
Opinion
Sports
Obituaries
Records
Contests
Services
About Us
Policies
Submit a News Tip
Submit a Photo
Submit a Sports Story
Letters to Editor
Pay Subscription
Classifieds
Calendar
Public Records
E-Edition